ClearPoint Neuro
CLPT
128 hedge funds and large institutions have $248M invested in ClearPoint Neuro in 2026 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 46 increasing their positions, 30 reducing their positions, and 11 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
100% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 11
84% more call options, than puts
Call options by funds: $13.1M | Put options by funds: $7.1M
76% more capital inflows, than outflows
Capital inflows: $30.5M | Capital outflows: $17.4M
53% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 30
8% more funds holding
Funds holding: 118 → 128 (+10)
2.55% more ownership
Funds ownership: 43.8% → 46.36% (+2.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAK Capital One
New York
|
+$5.93M |
| 2 |
BlackRock
New York
|
+$3.71M |
| 3 |
Pier Capital
Stamford,
Connecticut
|
+$2.78M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.71M |
| 5 |
Millennium Management
New York
|
+$1.57M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$4.06M |
| 2 |
SG Americas Securities
New York
|
-$3.39M |
| 3 |
Massar Capital Management
Stamford,
Connecticut
|
-$1.96M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.45M |
| 5 |
Vanguard Portfolio Management
Malvern,
Pennsylvania
|
-$1.13M |
CLPT Hedge Fund Activity: Q2 2026 in Review
128 of the 8,358 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q2 2026, worth a combined $248M — up 109% from $118M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new CLPT positions and 11 closed out — a net gain of 11 holders — while 46 added to existing stakes and 30 trimmed.
The largest buyer was MAK Capital One, adding an estimated $5.93M. The largest seller was Goldman Sachs, cutting an estimated $4.06M.
- 128 institutional investors held ClearPoint Neuro (CLPT) as of Q2 2026, up from 118 in Q1 2026.
- Funds reported $248M of ClearPoint Neuro stock for Q2 2026, up 109% quarter-over-quarter.
- 22 funds opened new ClearPoint Neuro positions in Q2 2026 and 11 closed out, a net change of +11 holders.
- The largest ClearPoint Neuro buyer in Q2 2026 was MAK Capital One, an estimated $5.93M added.
- The largest ClearPoint Neuro seller in Q2 2026 was Goldman Sachs, an estimated $4.06M sold.
Based on aggregated 13F filings for Q2 2026.